Effect of Chloroquine and Hydroxychloroquine on Cytokine Release Syndrome in Patients with COVID-19.

Ahmad, Bilal; Ul Hassan, Naeem; Sehar, Bismillah; Zeb, Falak; E Nayab, Dur; Siddiqui, Fuad Ahmad

Ahmad, Bilal; Ul Hassan, Naeem; Sehar, Bismillah; Zeb, Falak; E Nayab, Dur; Siddiqui, Fuad Ahmad.

Afiliação

Ahmad B; Department of Medicine, Pak Emirates Military Hospital, Rawalpindi-Pakistan.
Ul Hassan N; Department of Medicine, Combined Military Hospital, Rawalpindi-Pakistan.
Sehar B; Department of Public Health, National University of Medical Sciences, Rawalpindi-Pakistan.
Zeb F; Department of Human Nutrition and Dietetics, National University of Medical Sciences, Rawalpindi-Pakistan falak.zeb@numspak.edu.pk.
E Nayab D; Department of Paediatrics, Medic Hospital Rawalpindi.
Siddiqui FA; Department of Medicine, Combined Military Hospital, Rawalpindi-Pakistan.

Clin Med Res ; 19(4): 179-182, 2021 12.

Article em En | MEDLINE | ID: mdl-34933950

Assuntos

Tratamento Farmacológico da COVID-19; Hidroxicloroquina; Adulto; Antivirais/uso terapêutico; Cloroquina/uso terapêutico; Síndrome da Liberação de Citocina; Humanos; Hidroxicloroquina/uso terapêutico; Pessoa de Meia-Idade; SARS-CoV-2; Resultado do Tratamento; Adulto Jovem

Palavras-chave

COVID-19; Chloroquine; Coronavirus disease; Cytokine Release Syndrome; Hydroxychloroquine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 / Hidroxicloroquina Limite: Adult / Humans / Middle aged Idioma: En Ano de publicação: 2021

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google